Pomalyst Adverse Event Report 2018


This report includes data from the FDA’s Adverse Events Reports for 2018.  We removed reports where the subject of the report was taking only this drug. This report provides the following fields:

  • ID
  • Patient Summary
  • Patient Gender
  • Patient Age
  • Drug Products
  • Drug Reactions


Pomalyst (pomalidomide) affects the immune system. It promotes immune responses to help slow tumor growth. Pomalyst is used to treat multiple myeloma (cancer resulting from a progressive blood disease). It is usually given after at least two other medications have been tried without success. Pomalyst is available only from a certified pharmacy under a special program. You must be registered in the program and agree to use birth control measures as required.https://www.drugs.com/pomalyst.html